Cross-licensing of prescription and non-prescription drugs, transfer of production of preservative-free ophthalmics, and potential collaboration on the Russian market are the key components of a partnership signed by Polish group Polpharma and Croatia’s JGL. Executives from each firm have already started work on jointly implementing projects, and the parties expect to realize the first results of their collaboration within the next few months.
Through the collaboration, Polpharma will distribute certain undisclosed JGL products in Poland and other European markets. The Polish group has...
